{"title":"Reducing lead toxicity with advanced nanotechnology methods.","authors":"Alireza Ghassemi Toussi, Sadaf Sadat Rafati, Elham Einafshar","doi":"10.1007/s00210-025-04170-3","DOIUrl":null,"url":null,"abstract":"<p><p>Lead exposure remains a pressing global health concern, particularly due to its pervasive nature in our environment and the associated toxicological risks. This review article explores the multifaceted aspects of lead, including its physical and chemical properties, the epidemiological prevalence of lead poisoning, and the pathophysiological mechanisms underlying its toxicity. Clinical manifestations, particularly in occupational settings, highlight the significant health impacts on vulnerable populations. We will discuss current methodologies for the identification and detection of lead, emphasizing the importance of prevention and treatment strategies to mitigate exposure. Given the growing interest in sustainable remediation approaches, microbial remediation techniques are evaluated for their effectiveness in addressing lead contamination. Furthermore, this review underscores the potential of nanoparticles in modifying lead toxicity. Focusing on their role in both in vitro and in vivo conditions, we examine how nanoparticles can influence lead bioavailability and toxicity in various environments, including wastewater, soil, and plants. Our findings suggest that nanoparticles offer innovative solutions for reducing lead's harmful effects, thus providing a pathway for enhanced environmental and public health protection. This comprehensive review aims to inform researchers, healthcare professionals, and policymakers about the potential of cutting-edge nanotechnology methods in combating lead toxicity and improving health outcomes.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":"13205-13224"},"PeriodicalIF":3.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-04170-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Lead exposure remains a pressing global health concern, particularly due to its pervasive nature in our environment and the associated toxicological risks. This review article explores the multifaceted aspects of lead, including its physical and chemical properties, the epidemiological prevalence of lead poisoning, and the pathophysiological mechanisms underlying its toxicity. Clinical manifestations, particularly in occupational settings, highlight the significant health impacts on vulnerable populations. We will discuss current methodologies for the identification and detection of lead, emphasizing the importance of prevention and treatment strategies to mitigate exposure. Given the growing interest in sustainable remediation approaches, microbial remediation techniques are evaluated for their effectiveness in addressing lead contamination. Furthermore, this review underscores the potential of nanoparticles in modifying lead toxicity. Focusing on their role in both in vitro and in vivo conditions, we examine how nanoparticles can influence lead bioavailability and toxicity in various environments, including wastewater, soil, and plants. Our findings suggest that nanoparticles offer innovative solutions for reducing lead's harmful effects, thus providing a pathway for enhanced environmental and public health protection. This comprehensive review aims to inform researchers, healthcare professionals, and policymakers about the potential of cutting-edge nanotechnology methods in combating lead toxicity and improving health outcomes.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.